Shares of Novavax Inc. /zigman2/quotes/202614340/composite NVAX -2.88% tumbled 11.97% to $83.45 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -0.52% rising 1.28% to 14,194.45 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.45% rising 1.06% to 35,462.78. The stock's fall snapped a two-day winning streak. Novavax Inc. closed $248.23 below its 52-week high ($331.68), which the company reached on February 9th.
The stock underperformed when compared to some of its competitors Tuesday, as Replimune Group Inc. /zigman2/quotes/203971249/composite REPL +2.15% fell 1.55% to $18.48, VBI Vaccines Inc. /zigman2/quotes/201705917/composite VBIV -2.10% fell 1.23% to $1.60, and AnaptysBio Inc. /zigman2/quotes/205822596/composite ANAB +0.72% fell 1.83% to $31.15. Trading volume (9.0 M) eclipsed its 50-day average volume of 6.7 M.